ClinicalTrials.govpublic full text
Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance
gastric adenocarcinoma, cadonilimab, paclitaxel (albumin-bound), pd-(l)1 inhibitors resistance, esophagogastric junction adenocarcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801349
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.